# DAPTOMYCIN
> **NDA217415** · New Drug Application · Sponsor: HIKMA · Approved 2023-01-30
## Drug
- **FDA Application Number:** NDA217415
- **Application type:** New Drug Application
- **Brand name:** DAPTOMYCIN
- **Generic name:** DAPTOMYCIN
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Civica, Inc.
- **First approval:** 2023-01-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217415)
---
*AI Analytics · CC0 1.0*